PETS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PETS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-19), PetMed Express's share price is $4.10. PetMed Express's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.09. Hence, PetMed Express's Price-to-Free-Cash-Flow Ratio for today is 47.67.
The historical rank and industry rank for PetMed Express's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, PetMed Express's highest Price-to-Free-Cash-Flow Ratio was 2083.64. The lowest was 7.20. And the median was 18.28.
PetMed Express's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.18. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.09.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of PetMed Express was -92.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -15.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -14.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 11.30% per year.
During the past 13 years, PetMed Express's highest 3-Year average Free Cash Flow per Share Growth Rate was 261.50% per year. The lowest was -58.20% per year. And the median was 12.25% per year.
The historical data trend for PetMed Express's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PetMed Express's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where PetMed Express's Price-to-Free-Cash-Flow falls into.
PetMed Express's Price-to-Free-Cash-Flow ratio for today is calculated as
Price-to-Free-Cash-Flow Ratio | = | Share Price | / | Free Cash Flow per Share (TTM) |
= | 4.10 | / | 0.086 | |
= | 47.67 |
PetMed Express's Share Price of today is $4.10.
PetMed Express's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.09.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price-to-Free-Cash-Flow Ratio | = | Market Cap | / | Free Cash Flow |
PetMed Express (NAS:PETS) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Thank you for viewing the detailed overview of PetMed Express's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Gian Fulgoni | director | |
Christine Chambers | officer: CFO | 1501 1ST AVENUE SOUTH, STE. 600, SEATTLE WA 98134 |
Mathew N Hulett | director, officer: CEO & President | 1621 NORTH KENT STREET, SUITE 1200, ARLINGTON VA 22209 |
Campbell Leslie C.g. | director | C/O COUPA SOFTWARE INC., 1855 S. GRANT STREET, SAN MATEO CA 94402 |
Diana G Purcel | director | C/O FAMOUS DVES OF AMERICA INC, 8091 WALLACE ROAD, EDEN PRAIRIE MN 55344 |
Moseley Mark Bradley Jr | other: Chief Technology Info Officer | 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445 |
Daniel Job Pingree | other: Chief Marketing Officer | 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445 |
Sandra Yvette Campos | director | 4900 E DUBLIN GRANVILLE RD, COLUMBUS OH 43081 |
Jacqueline Paula Smith | other: Vice President of People | 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445 |
Carolyn Carden | other: VP of Product | 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445 |
Peter Cobb | director | DSW, INC., 810 DSW DRIVE, COLUMBUS OH 43219 |
Jodi Watson | director | 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445 |
Frank J Formica | director | 1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069 |
Bruce S Rosenbloom | officer: Chief Financial Officer | 6401 CONGRESS AVENUE, SUITE 250, BOCA RATON FL 33487 |
Menderes Akdag | director, officer: Chief Executive Officer | 1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069 |
From GuruFocus
By PurpleRose PurpleRose • 07-11-2022
By Marketwired • 07-31-2023
By Stock market mentor Stock market mentor • 01-23-2023
By PRNewswire • 11-27-2023
By GuruFocusNews GuruFocusNews • 06-18-2022
By PRNewswire • 01-08-2024
By PRNewswire • 11-14-2023
By Marketwired • 10-19-2023
By Business Wire • 11-09-2023
By sperokesalga sperokesalga • 05-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.